Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lagraauw HM"'
Publikováno v:
Cardiovascular Research; Jul2014, Vol. 103 Issue suppl_1, pS5-S5, 1p
Autor:
Tu YP; Clinical Pharmacology, ImmunoGen, Waltham, MA, USA., Lagraauw HM; qPharmetra LLC, Nijmegen, The Netherlands., Method M; Clinical Development, ImmunoGen, Waltham, MA, USA., Wang Y; Biostatistics, ImmunoGen, Waltham, MA, USA., Hanze E; qPharmetra LLC, Nijmegen, The Netherlands., Li L; Biostatistics, ImmunoGen, Waltham, MA, USA., Parrott T; Pharmacovigilance, ImmunoGen, Waltham, MA, USA., Sloss CM; Translational Science, ImmunoGen, Waltham, MA, USA., Westin EH; Clinical Development, ImmunoGen, Waltham, MA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Jan; Vol. 91 (1), pp. 220-231. Date of Electronic Publication: 2024 Sep 22.
Autor:
Schaedeli Stark F; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland. franziska.schaedeli_stark@roche.com., Chavanne C; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland., Derks M; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, Roche Products Ltd, Hexagon Place, 6 Falcon Way, Welwyn Garden City, AL7 1TW, UK., Jolling K; qPharmetra LLC, Kwakkenbergweg 39, 6523MK, Nijmegen, The Netherlands., Lagraauw HM; qPharmetra LLC, Kwakkenbergweg 39, 6523MK, Nijmegen, The Netherlands., Lindbom L; qPharmetra LLC, Kwakkenbergweg 39, 6523MK, Nijmegen, The Netherlands., Prins K; qPharmetra LLC, Kwakkenbergweg 39, 6523MK, Nijmegen, The Netherlands., Silber Baumann HE; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Jun; Vol. 51 (3), pp. 227-242. Date of Electronic Publication: 2024 Feb 03.
Autor:
Tu YP; Clinical Pharmacology, ImmunoGen, Waltham, Massachusetts, USA., Hanze E; qPharmetra LLC, Stockholm, Sweden., Zhu F; Bioanalysis, ImmunoGen, Waltham, Massachusetts, USA., Lagraauw HM; qPharmetra LLC, Nijmegen, The Netherlands., Sloss CM; Translational Science, ImmunoGen, Waltham, Massachusetts, USA., Method M; Clinical Development, ImmunoGen, Waltham, Massachusetts, USA., Esteves B; Clinical Development, ImmunoGen, Waltham, Massachusetts, USA., Westin EH; Clinical Development, ImmunoGen, Waltham, Massachusetts, USA., Berkenblit A; Clinical Development, ImmunoGen, Waltham, Massachusetts, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Feb; Vol. 90 (2), pp. 568-581. Date of Electronic Publication: 2023 Nov 13.
Autor:
Carrothers TJ; AbbVie, Madison, NJ, USA., Lagraauw HM; qPharmetra LLC, Cary, NC, USA., Lindbom L; qPharmetra LLC, Cary, NC, USA., Riccobene TA; AbbVie, Madison, NJ, USA.
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2023 Feb 01; Vol. 42 (2), pp. 99-105. Date of Electronic Publication: 2022 Nov 15.
Autor:
Lagraauw HM; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Boehringer Ingelheim Pharma GmbH & Co, Biberach an der Riß, Germany., Wezel A; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Haaglanden Medical Centre, Westeinde Hospital, The Hague, The Netherlands., van der Velden D; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Hogeschool Utrecht, Utrecht, The Netherlands., Kuiper J; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Bot I; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. i.bot@lacdr.leidenuniv.nl.
Publikováno v:
Scientific reports [Sci Rep] 2019 Feb 14; Vol. 9 (1), pp. 2134. Date of Electronic Publication: 2019 Feb 14.
Autor:
van der Velden D; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Lagraauw HM; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Wezel A; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Launay P; Université Paris Diderot, Sorbonne Paris Cité, Laboratoire d'Excellence INFLAMEX, Paris, France.; INSERM U1149, Centre de Recherche sur l'Inflammation, Université Paris Diderot, Paris, France., Kuiper J; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Huizinga TW; Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Toes RE; Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. r.e.m.toes@lumc.nl., Bot I; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Stoop JN; Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2016 Jun 13; Vol. 18 (1), pp. 138. Date of Electronic Publication: 2016 Jun 13.
Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages.
Autor:
Frodermann V; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., van Duijn J; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., van Puijvelde GH; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., van Santbrink PJ; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Lagraauw HM; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., de Vries MR; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Quax PH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Bot I; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Foks AC; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., de Jager SC; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Laboratory for Experimental Cardiology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Kuiper J; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Publikováno v:
Journal of internal medicine [J Intern Med] 2016 Jun; Vol. 279 (6), pp. 592-605. Date of Electronic Publication: 2016 Feb 23.
Autor:
Lagraauw HM; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Kuiper J; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Bot I; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Electronic address: i.bot@lacdr.leidenuniv.nl.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2015 Nov; Vol. 50, pp. 18-30. Date of Electronic Publication: 2015 Aug 06.
Autor:
Wezel A; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands †Division of Biopharmaceutics, LACDR, Leiden University, Leiden, The Netherlands ‡Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands §Idera Pharmaceuticals, Cambridge, MA., Welten SM, Razawy W, Lagraauw HM, de Vries MR, Goossens EA, Boonstra MC, Hamming JF, Kandimalla ER, Kuiper J, Quax PH, Nossent AY, Bot I
Publikováno v:
Annals of surgery [Ann Surg] 2015 Nov; Vol. 262 (5), pp. 841-7; discussion 847-8.